26
Vol. 66, No. 3 2015
Northeast Florida Medicine
Endovascular Neurosurgery
merous treatment modalities employed and the inherent
difficulty with comparison to the conservatively managed
cohorts, the evidence suggests that for unruptured AVMs,
it is not possible to conclude that conservative management
is superior to intervention. Further large-scale, prospective,
randomized studies are needed to better understand the
risks and benefits of treating this particular pathology.
Conclusions and Future Directions
The treatment of cerebral AVMs must be approached
strategically with a clear and logical plan in mind. Future
studies comparing the results of the application of modern
technological advancements in the treatment of AVMs with
patients left to conservative therapy is crucial for developing
a further understanding of the best management options
for patients. Multidisciplinary discussion amongst cere-
brovascular neurosurgeons, neuroendovascular specialists,
stroke neurologists, neuroradiologists, and radiosurgery
experts is also of absolute importance.
v
References
1. Ondra SL, Troupp H, George ED, Schwab K. The
natural history of symptomatic arteriovenous malfor-
mations of the brain: a 24-year follow-up assessment.
J
Neurosurg.
1990;73:387-391.
2. Stein BM, Wolpert SM. Arteriovenous malformations
of the brain. I: Current concepts and treatment.
Arch
Neurol.
1980;37:1-5.
3. Rothbart D, Awad IA, Lee J, et al. Expression of
angiogenic factors and structural proteins in central
nervous system vascular malformations.
Neurosurgery.
1996;38:915-925.
4. Wallace RC, Flom RA, Khayata MH, et al. The safety
and effectiveness of brain arteriovenous malformation
embolization using acrylic and particles: the experiences
of a single institution.
Neurosurgery.
1995;37:606-618.
5. Thompson RC, Steinberg GK, Levy RP, Marks MP. The
management of patients with arteriovenous malforma-
tions and associated intracranial aneurysms.
Neurosur-
gery.
1998;43:202-212.
6. Mansmann U, Meisel J, Brock M, et al Factors as-
sociated with intracranial hemorrhage in cases of
cerebral arteriovenous malformation.
Neurosurgery.
2000;46:272-281.
7. Heros RC, Korosue K, Diebold PM. Surgical excision
of cerebral arteriovenous malformations: late results.
Neurosurgery.
1990;26:570-578.
8. Heros RC, Morcos J, Korosue K. Arteriovenous mal-
formations of the brain. Surgical management.
Clin
Neurosurg.
1993;40:139-173.
9. Spetzler RF, Martin NA. A proposed grading system for ar-
teriovenous malformations.
J Neurosurg.
1986;65:476-483.
10. Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD.
A dose-response analysis of arteriovenous malformation
obliteration after radiosurgery.
Int J Radiat Oncol Biol
Phys.
1996;36:873-879.
11. Kondziolka D, Lunsford LD, Kanal E, Talagala L. Ste-
reotactic magnetic resonance angiography for targeting
in arteriovenous malformation radiosurgery.
Neurosur-
gery.
1994;35:585-591.
12. Pollock BE, Lunsford LD, Flickinger JC, Kondziolka D.
The role of embolization in combination with stereo-
tactic radiosurgery in the management of pial and dural
arteriovenous malformations. In: Connors JJ, Wojak
JC, eds.
Interventional Neuroradiology.
Philadelphia:
W.B. Saunders; 1999:267-275.
13. Jafar JJ, Davis AJ, Berenstein A, et al. The effect of em-
bolization with N-butyl cyanoacrylate prior to surgical
resection of cerebral arteriovenous malformations.
J
Neurosurg.
1993;78:60-69.
14. Gobin YP, Laurent A, Merienne L, Schlienger M,
Aymard A, Houdart E, Casasco A, Lefkopoulos D,
George B, Merland JJ. Treatment of brain arteriovenous
malformations by embolization and radiosurgery.
J
Neurosurg.
1996;85:19-28.
15. Wikholm G, Lundqvist C, Svendsen P. The Goteberg co-
hort of embolized cerebral arteriovenous malformations:
a 6-year follow-up.
Neurosurgery.
2001;49:799-806.
16. Batjer HH, Purdy PD, Giller CA, Samson DS. Evi-
dence of redistribution of cerebral blood flow during
treatment for an intracranial arteriovenous malforma-
tion.
Neurosurgery.
1989;25:599-605.
17. Mohr JP, Parides MK, Stapf C, et al. for the interna-
tional ARUBA Investigators. Medical management with
or without interventional therapy for unruptured brain
arteriovenous malformations (ARUBA): a multicentre,
non-blinded, randomised trial.
Lancet.
2014;383:614-
621.
18. Al-Shahi SR, White PM, Counsell CE, et al. for the
Scottish Audit of Intracranial Vascular Malformations
Collaborators. Outcome After Conservative Manage-
ment or Intervention for Unruptured Brain Ateriove-
nous Malformations.
JAMA.
2014;311(16):1661-1669.
19. Van Beijnum J, van der Worp HB, Buis DR, et al.
Treatment of Brain Arteriovenous Malformations
A Systematic Review and Meta-analysis.
JAMA.
2011;306(18).2011-2019.